{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:28:59Z","timestamp":1695947339696},"reference-count":62,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.3816\/clm.2006.n.012","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:34Z","timestamp":1221095434000},"page":"373-379","source":"Crossref","is-referenced-by-count":6,"title":["The Role of High-Dose Therapy in Peripheral T-Cell Lymphomas"],"prefix":"10.3816","volume":"6","author":[{"given":"Peter","family":"Reimer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"R\u00fcdiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2006.n.012_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/asheducation-2001.1.259","article-title":"T cell and NK cell lymphoproliferative disorders","author":"Greer","year":"2001","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.3816\/CLM.2006.n.012_bib2","series-title":"Cancer. Principles and Practice of Oncology","first-page":"2256","article-title":"Non-Hodgkin's lymphomas","author":"Shipp","year":"2001"},{"key":"10.3816\/CLM.2006.n.012_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/1097-0142(19830715)52:2<318::AID-CNCR2820520221>3.0.CO;2-G","article-title":"Angioimmunoblastic lymphadenopathy. Long-term follow-up study","volume":"52","author":"Pangalis","year":"1983","journal-title":"Cancer"},{"key":"10.3816\/CLM.2006.n.012_bib4","first-page":"503","article-title":"High-dose chemotherapy and autologous bone marrow transplantation in relapsing angioimmunoblastic lymphadenopathy with dysproteinemia (AILD)","volume":"8","author":"Schmitz","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2006.n.012_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0145-2126(00)00134-X","article-title":"High-dose chemotherapy and APSCT as a potential cure for relapsing hemolysing AILD","volume":"25","author":"Lindahl","year":"2001","journal-title":"Leuk Res"},{"issue":"suppl","key":"10.3816\/CLM.2006.n.012_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/annonc\/mdg703","article-title":"Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease","volume":"14","author":"Hertzberg","year":"2003","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00277-002-0526-8","article-title":"High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases","volume":"81","author":"Tsuchiyama","year":"2002","journal-title":"Ann Hematol"},{"key":"10.3816\/CLM.2006.n.012_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.bmt.1700606","article-title":"Autologous bone marrow transplantation for primary nasal T\/NK cell lymphoma","volume":"19","author":"Liang","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2006.n.012_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood.V76.2.424.424","article-title":"Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non- Hodgkin's lymphomas","volume":"76","author":"Vose","year":"1990","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.012_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1701596","article-title":"Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT)","volume":"23","author":"Fanin","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2006.n.012_bib11","first-page":"294a","article-title":"High dose chemotherapy and hematopoietic stem cell transplant in peripheral T cell, NK cell and Ki-1 anaplastic large sell lymphoma","volume":"20","author":"Jagasia","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"suppl 1","key":"10.3816\/CLM.2006.n.012_bib12","first-page":"173a","article-title":"High dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) in peripheral T-cell lymphoma (PTCL). A single institution experience","volume":"94","author":"Haider","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.012_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","article-title":"High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas","volume":"27","author":"Blystad","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2006.n.012_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00277-002-0556-2","article-title":"Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation","volume":"81","author":"Kahl","year":"2002","journal-title":"Ann Hematol"},{"key":"10.3816\/CLM.2006.n.012_bib15","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","article-title":"Impact of high-dose chemotherapy on peripheral T-cell lymphomas","volume":"19","author":"Rodriguez","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1365-2141.2003.04203.x","article-title":"Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype","volume":"120","author":"Song","year":"2003","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2006.n.012_bib17","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/annonc\/mdg459","article-title":"High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience","volume":"14","author":"Rodriguez","year":"2003","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1704367","article-title":"Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey","volume":"33","author":"Jantunen","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2006.n.012_bib19","first-page":"1272","article-title":"Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation","volume":"88","author":"Schetelig","year":"2003","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2006.n.012_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00277-003-0647-8","article-title":"Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation","volume":"82","author":"Reimer","year":"2003","journal-title":"Ann Hematol"},{"key":"10.3816\/CLM.2006.n.012_bib21","first-page":"47","article-title":"High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult highgrade malignant T-cell non-Hodgkin's lymphoma\u2013a pilot clinical study","volume":"15","author":"Wu","year":"1993","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.3816\/CLM.2006.n.012_bib22","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1200\/JCO.2000.18.16.3025","article-title":"Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol\u2013a groupe d'Etude des lymphomes de l'Adulte study","volume":"18","author":"Haioun","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib23","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1200\/JCO.2002.20.5.1426","article-title":"Impact of high-dose chemotherapy on peripheral T-cell lymphomas","volume":"20","author":"Mounier","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib24","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2002.02.125","article-title":"Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma","volume":"20","author":"Gisselbrecht","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.thj.6200359","article-title":"Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation (APBSCT) as first-line therapy in peripheral T cell lymphomas (PTCL). First results of a prospective multicenter study","volume":"5","author":"Reimer","year":"2004","journal-title":"Hematology J"},{"issue":"suppl","key":"10.3816\/CLM.2006.n.012_bib26","first-page":"568a","article-title":"Autologous stem cell transplantation as first-line therapy in peripheral T-cell lymphomas. A prospective multicenter study","volume":"106","author":"Reimer","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.012_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ajh.2830470406","article-title":"High expression of CD56 (NCAM) in a patient with cutaneous CD4-positive lymphoma","volume":"47","author":"Adachi","year":"1994","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2006.n.012_bib28","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood.V97.10.3210","article-title":"Identification of a leukemic counterpart of the plasmacytoid dendritic cells","volume":"97","author":"Chaperot","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.012_bib29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bmt.1704215","article-title":"What is CD4+CD56+ malignancy and how should it be treated?","volume":"32","author":"Reimer","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2006.n.012_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000046533","article-title":"Nodal gamma\/delta T cell lymphoma in complete remission following allogeneic bone marrow transplantation from an HLA-matched unrelated donor","volume":"105","author":"Aoyama","year":"2001","journal-title":"Acta Haematol"},{"key":"10.3816\/CLM.2006.n.012_bib31","first-page":"263","article-title":"Successful treatment of relapsed T-cell non- Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning","volume":"69","author":"Oji","year":"1999","journal-title":"Int J Hematol"},{"key":"10.3816\/CLM.2006.n.012_bib32","first-page":"E25","article-title":"Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma","volume":"86","author":"Ooi","year":"2001","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2006.n.012_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF02982726","article-title":"Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions","volume":"76","author":"Makita","year":"2002","journal-title":"Int J Hematol"},{"key":"10.3816\/CLM.2006.n.012_bib34","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","article-title":"Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation for hematopoietic cells","volume":"22","author":"Corradini","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.bmt.1705036","article-title":"Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma","volume":"36","author":"Wulf","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2006.n.012_bib36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-117-5-364","article-title":"Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM\/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group","volume":"117","author":"Siegert","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.3816\/CLM.2006.n.012_bib37","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy- sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2006.n.012_bib38","first-page":"75","article-title":"Successful treatment of disseminated nasal NK\/T-cell lymphoma using double autologous peripheral blood stem cell transplantation","volume":"71","author":"Sasaki","year":"2000","journal-title":"Int J Hematol"},{"key":"10.3816\/CLM.2006.n.012_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/10428199909058412","article-title":"Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature","volume":"32","author":"Pautier","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2006.n.012_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1011144911781","article-title":"CHOP followed by involved field radiation: is it optimal for localized nasal natural killer\/T-cell lymphoma?","volume":"12","author":"Kim","year":"2001","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib41","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. classification","volume":"9","author":"Lopez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib42","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","article-title":"Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma","volume":"93","author":"Gascoyne","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.012_bib43","first-page":"2697","article-title":"ALK+ lymphoma: clinico-pathological findings and outcome","volume":"93","author":"Falini","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.012_bib44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1008200307625","article-title":"Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. classification","volume":"8","author":"Ascani","year":"1997","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib45","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","author":"Anonymous","year":"1997","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.012_bib46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non- Hodgkin's Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/1097-0142(1984)54:4<687::AID-CNCR2820540416>3.0.CO;2-G","article-title":"Caribbean T-cell lymphoma\/leukemia","volume":"54","author":"Swerdlow","year":"1984","journal-title":"Cancer"},{"key":"10.3816\/CLM.2006.n.012_bib48","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/1097-0142(19930901)72:5<1762::AID-CNCR2820720541>3.0.CO;2-D","article-title":"Clinicopathologic study of 212 cases of peripheral T-cell lymphoma among the Japanese","volume":"72","author":"Nakamura","year":"1993","journal-title":"Cancer"},{"key":"10.3816\/CLM.2006.n.012_bib49","series-title":"World Health Organization Classification of Tumours: Pathology & Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"189","article-title":"Mature T-cell and NK-cell neoplasms","author":"Jaffe","year":"2001"},{"key":"10.3816\/CLM.2006.n.012_bib50","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","article-title":"Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma","volume":"15","author":"Ansell","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib51","first-page":"171","article-title":"Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome","volume":"82","author":"Zaja","year":"1997","journal-title":"Haematologica"},{"issue":"suppl 4","key":"10.3816\/CLM.2006.n.012_bib52","first-page":"63","article-title":"International Prognostic Index (IPI) valid for T-cell lymphoma","volume":"25","author":"Sonnen","year":"2002","journal-title":"Onkologie"},{"key":"10.3816\/CLM.2006.n.012_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2559.1993.tb00128.x","article-title":"Peripheral T-cell lymphoma: a clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification","volume":"22","author":"Montalban","year":"1993","journal-title":"Histopathology"},{"key":"10.3816\/CLM.2006.n.012_bib54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2559.1999.00721.x","article-title":"Clinicopathological analysis of 501 non- Hodgkin's lymphomas in Korea according to the revised European- American classification of lymphoid neoplasms","volume":"35","author":"Lee","year":"1999","journal-title":"Histopathology"},{"key":"10.3816\/CLM.2006.n.012_bib55","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1200\/JCO.1989.7.6.725","article-title":"Direct comparisons of peripheral Tcell lymphoma with diffuse B-cell lymphoma of comparable histological grades\u2013should peripheral T-cell lymphoma be considered separately?","volume":"7","author":"Cheng","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib56","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1200\/JCO.1991.9.8.1426","article-title":"Similar outcome of treatment of Bcell and T-cell diffuse large-cell lymphomas: the Stanford experience","volume":"9","author":"Kwak","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib57","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1200\/JCO.1989.7.12.1783","article-title":"Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma","volume":"7","author":"Armitage","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib58","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.012_bib59","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","article-title":"Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma","volume":"89","author":"Melnyk","year":"1997","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.012_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","article-title":"Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives)","volume":"1","author":"Coiffier","year":"1990","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2006.n.012_bib61","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V72.2.436.436","article-title":"The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype","volume":"72","author":"Lippman","year":"1988","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.012_bib62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B","article-title":"Peripheral T-cell lymphoma","volume":"63","author":"Armitage","year":"1989","journal-title":"Cancer"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011704164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011704164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:09:36Z","timestamp":1588918176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011704164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1557919011704164"],"URL":"https:\/\/doi.org\/10.3816\/clm.2006.n.012","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}